Atherosclerosis Independence: Genetic Polymorphisms of Ion Channels Role in the Pathogenesis of Coronary Microvascular Dysfunction and Myocardial Ischemia (Coronary Artery Disease (CAD)) Reviewer and Co-Curator: Larry H Bernstein, MD, FCAP and Curator: Aviva Lev-Ari, PhD, RN The role of ion channels in Na(+)-K(+)-ATPase: regulation of ion transport across the plasma membrane has been studied by our Team in […]
Search Results for 'Ion Channel'
Atherosclerosis Independence: Genetic Polymorphisms of Ion Channels Role in the Pathogenesis of Coronary Microvascular Dysfunction and Myocardial Ischemia (Coronary Artery Disease (CAD))
Posted in Cardiovascular Pharmacogenomics, Diabetes Mellitus, Frontiers in Cardiology and Cardiovascular Disorders, Genome Biology, Genomic Testing: Methodology for Diagnosis, Ionic Transporters Na+, K, Molecular Genetics & Pharmaceutical, Na-K transport, Na-K-ATPase, Nitric Oxide in Health and Disease, Origins of Cardiovascular Disease, Population Health Management, Genetics & Pharmaceutical, Proteomics, tagged ATO2A@, ATPase, Aviva Lev-Ari, CAD, Coronary artery disease, Coronary circulation, coronary microvascular dysfunction, eNOS, genetic polymorphisms, Heart disease, Heart Failure, Hebrew University of Jerusalem, ion channels, ischemic heart diases (IHD), KCN5A gene (Kv1.5 channel), Kir6, Myocardial Ischemia, Nav 1.5, non-modifiable protective factor, NOS encoding, rs5215_GG, rs5219_AA, SCN5A, Thomas C. Südhof, voltage-gated K ion channel on December 21, 2013| 15 Comments »
Beta Blockers vs Calcium Channel Blockers for Atrial Fibrillation Rate Control: Thinking Beyond the ED
Posted in Uncategorized on August 9, 2015| Leave a Comment »
Beta Blockers vs Calcium Channel Blockers for Atrial Fibrillation Rate Control: Thinking Beyond the ED Sourced through Scoop.it from: http://www.aliem.com See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY
Optogenetics: The Promise for development of Biological Alternatives to the Electronic Pacemaker: Pacing and Resynchronizing Heartbeat by Activating Light-sensitive Proteins: ion-channel ChR2, overexpressed in Excitable cells in Heart Muscle Cells to modulate their Electrical Activity
Posted in Cardiac muscle regeneration, Competition in regenerative stem cell science, Electrophysiology, Frontiers in Cardiology and Cardiovascular Disorders, Gene Regulation, Genome Biology, Stem Cells for Regenerative Medicine on July 14, 2015| Leave a Comment »
Optogenetics: The Promise for development of Biological Alternatives to the Electronic Pacemaker: Pacing and Resynchronizing Heartbeat by Activating Light-sensitive Proteins: ion-channel ChR2, overexpressed in Excitable cells in Heart Muscle Cells to modulate their Electrical Activity Reporter: Aviva Lev-Ari, PhD, RN Optogenetics for in vivo cardiac pacing and resynchronization therapies Udi Nussinovitch & Lior Gepstein Affiliations Contributions […]
CONTROLLED RELEASE FORMULATION OF ANTIHYPERTENSIVE DRUGS: Design and Optimization of Controlled Release Formulations for Calcium Channel Blockers
Posted in Uncategorized on December 22, 2014| Leave a Comment »
CONTROLLED RELEASE FORMULATION OF ANTIHYPERTENSIVE DRUGS: Design and Optimization of Controlled Release Formulations for Calcium Channel Blockers Offer Price $114.00 ISBN:3844392416 Authors Dr. Dheeraj Baviskar, Dr. Source: booksonthemove.com See on Scoop.it – Cardiotoxicity
Ischemia-Related Subcellular Redistribution of Sodium Channels Enhances the Proarrhythmic Effect of Class I Antiarrhythmic Drugs: A Simulation Study
Posted in Uncategorized on October 10, 2014| Leave a Comment »
PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world. Source: http://www.plosone.org See on Scoop.it – Cardiovascular and vascular imaging
Atrial Fibrillation Rate Control in the ED: Calcium Channel Blockers or Beta Blockers?
Posted in Uncategorized on September 12, 2014| Leave a Comment »
Atrial Fibrillation Rate Control in the ED: Calcium Channel Blockers or Beta Blockers? (MT”@MDaware: dilt or metoprolol for AF w/RVR?” Same ? Source: http://www.aliem.com See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY
Voltage-Gated Calcium Channel and Pharmacogenetic Association with Adverse Cardiovascular Outcomes: Hypertension Treatment with Verapamil SR (CCB) vs Atenolol (BB) or Trandolapril (ACE)
Posted in Cardiovascular Pharmacogenomics, Chemical Genetics, Computational Biology/Systems and Bioinformatics, Frontiers in Cardiology and Cardiovascular Disorders, Genome Biology, Genomic Testing: Methodology for Diagnosis, HTN, Personalized and Precision Medicine & Genomic Research, Pharmacogenomics, Pharmacotherapy of Cardiovascular Disease, Population Health Management, Genetics & Pharmaceutical on January 2, 2014| 2 Comments »
Voltage-Gated Calcium Channel and Pharmacogenetic Association with Adverse Cardiovascular Outcomes: Hypertension Treatment with Verapamil SR (CCB) vs Atenolol (BB) or Trandolapril (ACE) Reporter: Aviva Lev-Ari, PhD, RN Genetic Variation in the β2 Subunit of the Voltage-Gated Calcium Channel and Pharmacogenetic Association With Adverse Cardiovascular Outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES) Yuxin Niu, […]
Calcium-Channel Blocker, Calcium as Neurotransmitter Sensor and Calcium Release-related Contractile Dysfunction (Ryanopathy)
Posted in Calcium Signaling, Cardiovascular Pharmacogenomics, Cell Biology, Signaling & Cell Circuits, Disease Biology, Small Molecules in Development of Therapeutic Drugs, Electrophysiology, Frontiers in Cardiology and Cardiovascular Disorders, tagged Aviva Lev-Ari, Bernard Katz, Calcium-Channel Blocker, gene therapy, Heart Failure, Larry H. Bernstein, Michael J Berridge, Smooth muscle tissue, Stanford University, Vascular smooth muscle on September 16, 2013| 25 Comments »
Calcium-Channel Blocker, Calcium Release-related Contractile Dysfunction (Ryanopathy) and Calcium as Neurotransmitter Sensor Author, and Content Consultant to e-SERIES A: Cardiovascular Diseases: Justin Pearlman, MD, PhD, FACC Author and Curator: Larry H Bernstein, MD, FCAP and Article Curator: Aviva Lev-Ari, PhD, RN Introduction Author: Larry H Bernstein, MD, FACC This Chapter is one of a series of articles on […]
MGH’s Largest-ever Genetic Study of Five Psychiatric Disorders: Variation in SNPs in Two Genes involved in Calcium-Channel Signaling
Posted in Biological Networks, Gene Regulation and Evolution, Biomarkers & Medical Diagnostics, Cell Biology, Signaling & Cell Circuits, Cerebrovascular and Neurodegenerative Diseases, Chemical Genetics, Computational Biology/Systems and Bioinformatics, Genome Biology, Genomic Testing: Methodology for Diagnosis, Medical and Population Genetics, Molecular Genetics & Pharmaceutical, Personalized and Precision Medicine & Genomic Research, Pharmacogenomics, Population Health Management, Genetics & Pharmaceutical, tagged Lancet, Major depressive disorder, Massachusetts General Hospital, National Institute of Mental Health, Perelman School of Medicine, Smoller, University of Bologna on February 28, 2013| 2 Comments »
Reporter: Aviva Lev-Ari, PhD, RN Five Psych Disorders Have Common Genetics By Michael Smith, North American Correspondent, MedPage Today Published: February 27, 2013 Reviewed by Zalman S. Agus, MD; Emeritus Professor, Perelman School of Medicine at the University of Pennsylvania Action Points The findings in this study show that specific single-nucleotide polymorphisms are associated with a range […]
